A woman who was repeatedly turned away by doctors despite showing early signs of breast cancer is now battling stage four cancer that has spread to her brain and lungs.
Lea Hughes, 38, from east London, first noticed a small lump in her right breast back in 2015. At just 29 years old, she wasted no time and sought medical advice. But the response she received was far from reassuring.
“The doctor told me I just had ‘lumpy boobs.’ I’d never even heard that term before,” Lea recalled. “I didn’t qualify for further testing. That was it.”
But Lea didn’t forget the lump. Two years later, while trying on a bikini, she noticed a shadow cast by the same lump—and saw that it had turned into a noticeable dimple. Alarmed, she contacted her doctor again.
This time, she was referred directly to hospital. After a mammogram, ultrasound, and biopsy, the results confirmed what she feared: it was breast cancer.
But by then, the disease had already begun its deadly spread.
“They did a breast MRI and saw a shadow on my liver. More scans followed—PETs, bone scans—and within weeks, they told me it had spread to my liver and bones. I was diagnosed with incurable stage four cancer on Friday the 13th, April 2018.”
Lea began aggressive treatment and underwent a single mastectomy in 2022. She received chemotherapy and, by May 2024, her doctors believed the cancer was under control. Her treatments were halted.
But the reprieve was short-lived.
A routine scan months later revealed her liver tumors were growing again—and worse, the cancer had reached her brain.
“It’s always in the back of your mind with stage four breast cancer—that it might spread to your brain. But I had no symptoms at all. I didn’t expect it then,” she said.
Since then, Lea has endured further rounds of radiotherapy and chemotherapy. The physical toll has been brutal.
“I’m 5ft 10in and dropped to just 7 stone (98 lbs). I couldn’t hold myself up. I was wasting away,” she said. “I shaved my head when I started losing my hair. I didn’t recognize myself anymore. It was heartbreaking.”
In March 2025, scans confirmed that the cancer had spread again—this time to her lungs. She is now undergoing her sixth course of chemotherapy and is in a race against time to access a potentially life-saving drug called Enhertu.
While Enhertu is available on the NHS for certain types of breast cancer, it isn’t approved in Lea’s case due to the cancer’s presence in her brain. Without government funding, the treatment costs more than £10,000 ($13,745) per cycle.
Still, Lea is determined to fight. She’s launched a fundraiser to help cover the cost of the drug, which has shown promising results in trials for patients with both breast and brain metastases.
“I don’t have a choice,” she said. “I just have to get on with it and keep fighting.”
Her story is a sobering reminder of the importance of early detection—and the devastating consequences of being ignored.
Be First to Comment